Idera Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Idera Pharmaceuticals patents 8 in total
Status | Patent |
---|---|
Application | Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT Filling date: 8 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: TLR9 MODULATORS FOR TREATING CANCER Filling date: 8 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: USE OF A TLR9 AGONIST IN METHODS FOR TREATING COVID-19 Filling date: 8 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT Filling date: 8 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS Filling date: 8 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT Filling date: 8 Sep 2025 Issue date: 20 Feb 2020 |
Showing 1 to 8 of 8 patents.